Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

OBJECTIVE: To evaluate if daily oral 75 µg of Desogestrel (DSG) for 3 months prior to the insertion of etonogestrel-releasing contraceptive implant (ENG-IMPLANT) might help reduce its premature discontinuation. RESULTS: A total of 66 women were randomized in the ENG-IMPLANT group (26) and in the DSG...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi Fäh, Valeria, Catarino, Rosa, Castillo, Sarah, Badda, Maria, Gezer-Dickschat, Sibel, Thieringer, Friederike, Tschudin, Sibil, Viviano, Manuela, Yaron, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010063/
https://www.ncbi.nlm.nih.gov/pubmed/36915205
http://dx.doi.org/10.1186/s13104-023-06304-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010063/
https://www.ncbi.nlm.nih.gov/pubmed/36915205
http://dx.doi.org/10.1186/s13104-023-06304-3

Ejemplares similares